Stockreport

AMAG Pharmaceuticals Announces Pricing of $300 Million of 3.25% Convertible Senior Notes Due 2022

AMAG PHARMACEUTICALS  (AMAG) 
Last amag pharmaceuticals earnings: 3/4 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: amagpharma.com/investors
PDF WALTHAM, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (“AMAG”) (Nasdaq:AMAG) today announced the pricing of $300 million aggregate principal amou [Read more]